<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>视网膜色素变性自救之家 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-04T16:19:09+08:00</updated>
  <subtitle>夜空中最亮的星能否记起曾与我同行消失在风里的身影我祈祷拥有一颗透明的心灵和会流泪的眼睛给我再去相信的勇气</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【杭州医保福利】不限年龄职业、健康状况既往症，只要有基本医保就能投保</title>
    <updated>2021-01-04T13:36:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/-bXH22d6Izij6gj_QOWY1Q</id>
    <link href="https://mp.weixin.qq.com/s/-bXH22d6Izij6gj_QOWY1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>改变人类健康：治疗失明的更好结果</title>
    <updated>2020-12-30T12:02:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/4yrw5FO7EeBlsZfafrnHlA</id>
    <link href="https://mp.weixin.qq.com/s/4yrw5FO7EeBlsZfafrnHlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>7种罕见病药品纳入2020年国家医保药品目录 | 政策</title>
    <updated>2020-12-29T12:02:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/QQwbwtfKPtt40paaY27OnQ</id>
    <link href="https://mp.weixin.qq.com/s/QQwbwtfKPtt40paaY27OnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明年起罕见病药品原料、特殊患儿所需食品等实行零关税 | 政策</title>
    <updated>2020-12-28T12:46:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/2gGb4AGt9duE9ZKwJP0pmg</id>
    <link href="https://mp.weixin.qq.com/s/2gGb4AGt9duE9ZKwJP0pmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>USH2A视网膜病变：从遗传学到治疗学</title>
    <updated>2020-12-25T13:51:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/QwippDIDANGi4owneTuH5g</id>
    <link href="https://mp.weixin.qq.com/s/QwippDIDANGi4owneTuH5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首都医科大学基于RB1基因突变干细胞定向诱导分化为视网膜类器官</title>
    <updated>2020-12-23T09:27:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/4OPCOrw-bY2b8dtkP_5Ixg</id>
    <link href="https://mp.weixin.qq.com/s/4OPCOrw-bY2b8dtkP_5Ixg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GyroscopeTherapeutics与宾夕法尼亚大学宣布研究协议以开发用于严重眼疾的基因疗法</title>
    <updated>2020-12-22T11:56:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/RaKj4itbZjdxDZxWql0mvg</id>
    <link href="https://mp.weixin.qq.com/s/RaKj4itbZjdxDZxWql0mvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>视网膜色素变性患者的平凡人生（九）</title>
    <updated>2020-12-21T13:28:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/JS9pWgh23459RcqCd4Xxjg</id>
    <link href="https://mp.weixin.qq.com/s/JS9pWgh23459RcqCd4Xxjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Atsena Therapeutics筹集了5500万美元的A轮融资，以推进LCA1（Gucy2d）基因治疗临床计划</title>
    <updated>2020-12-18T08:09:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/LV0xaQZyzplga_BWSznDwA</id>
    <link href="https://mp.weixin.qq.com/s/LV0xaQZyzplga_BWSznDwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医保局：符合条件的罕见病药已基本纳入医保</title>
    <updated>2020-12-17T12:59:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/vnPw14t-fNF0vaTt-VsUeA</id>
    <link href="https://mp.weixin.qq.com/s/vnPw14t-fNF0vaTt-VsUeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>